Pfizer (PFE) Tops Q1 EPS by 25c; reaffirms guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $27.79 -2.32%
EPS Growth %: -12.6%
Financial Fact:
Selling, informational and administrative expenses: 3.56B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -12.6%
Financial Fact:
Selling, informational and administrative expenses: 3.56B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $1.23, $0.25 better than the analyst estimate of $0.98. Revenue for the quarter came in at $18.3 billion versus the consensus estimate of $16.64 billion.
GUIDANCE:
Pfizer sees FY2023 EPS of $3.25-$3.45, versus the consensus of $3.36. Pfizer sees FY2023 revenue of $67-71 billion, versus the consensus of $68.67 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- HSBC Raises S&P500 Target to 8,100
- Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
